August 4, 2014 | EndyMed, an Israeli medical equipment developer creating equipment based on radio frequency technologies, signed an agreement with Chinese company OHMK Medical Technology for $7 million. OHMK will acquire 47.93 million EndyMed shares, giving OHMK a 37.21 percent stake in the company. OHMK markets EndyMed’s products EndyMed Glow and EndyMed Pro in China. Founded in 2007, EndyMed is a medical technology company specializing in the design, development and sale of energy based aesthetic treatments. The company’s products have been approved by the Food & Drug Administration in the United States and China.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments